Birmingham, AL, United States of America

Shri Niwas

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignees: Biocryst Pharmaceuticals, Inc., Biocryst, Inc.. Active years: 1993-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shri Niwas. Retrieved from https://idiyas.com/inventor/shri-niwas-x8da7cy3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 155(Granted Patents)


Company Filing History:


Years Active: 1993-2005

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Shri Niwas: A Contributor to Medical Advancements

Introduction

Shri Niwas is a renowned inventor based in Birmingham, AL, known for his significant contributions to the field of medicinal chemistry. With a portfolio of five patents, he has made notable strides in developing innovative compounds aimed at addressing serious health issues, particularly those related to clotting disorders.

Latest Patents

Among his latest patents, Shri Niwas has developed biaryl compounds that act as serine protease inhibitors. These compounds are particularly effective against trypsin-like serine protease enzymes, including thrombin, factor VIIa, factor Xa, and TF/FVIIa. The potential applications of these compounds are vast, as they are designed to treat and prevent clotting disorders, acting as crucial anticoagulating agents.

Career Highlights

Shri Niwas has enjoyed a successful career and has been associated with notable pharmaceutical firms, including Biocryst Pharmaceuticals, Inc. and Biocryst, Inc. His expertise in medicinal chemistry and innovative approach toward drug discovery has positioned him as a key figure in the industry, further solidifying his reputation as an influential inventor.

Collaborations

Throughout his career, Shri Niwas has collaborated with accomplished professionals, including Yarlagadda Sudhakara Babu and R. Scott Rowland. These collaborations have fostered an environment of innovation, allowing for the exchange of ideas and expertise, leading to groundbreaking developments in his field.

Conclusion

In conclusion, Shri Niwas’s inventive spirit and dedication to addressing complex medical challenges have resulted in significant advancements in pharmaceuticals. His groundbreaking work on biaryl compounds serves as a testament to his commitment to improving health outcomes and showcases the impact of innovation in the realm of medicine. As he continues to pursue research and development, the medical community eagerly anticipates his future contributions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…